Area of research
Nephrology · Genetics
Research interest
Research interests include Parathyroid Disorders and Treatments, Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes, and Genetic and Kidney Cyst Diseases.
Overweight Status, Obesity, and Progression to ESKD in Patients with Autosomal Dominant Polycystic Kidney Disease
Barriers and Facilitators to Home Dialysis Among Latinx Patients with Kidney Disease
Time-efficient, high-resistance inspiratory muscle strength training increases cerebrovascular reactivity in midlife and older adults
Sources of Clinician Burnout in Providing Care for Underserved Patients in a Safety-Net Healthcare System
Time‐Efficient Inspiratory Muscle Strength Training Lowers Blood Pressure and Improves Endothelial Function, NO Bioavailability, and Oxidative Stress in Midlife/Older Adults With Above‐Normal Blood Pressure
Social and Cultural Challenges in Caring for Latinx Individuals With Kidney Failure in Urban Settings
Effect of Intensive Blood Pressure Control on Aortic Stiffness in the SPRINT-HEART
Deoxycholic Acid and Risks of Cardiovascular Events, ESKD, and Mortality in CKD: The CRIC Study
Deoxycholic Acid (DCA) and Cognitive Impairment and Decline in the Chronic Renal Insufficiency Cohort (CRIC) Study
Short-term time-restricted feeding is safe and feasible in non-obese healthy midlife and older adults
Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation
Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology–Polycystic Kidney Disease (SONG-PKD) Consensus Workshop
Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants
Mineral bone disease in autosomal dominant polycystic kidney disease
<scp>FGF23</scp> , Frailty, and Falls in <scp>SPRINT</scp>
Arterial stiffness and kidney disease progression in the systolic blood pressure intervention trial
Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT
Serum bicarbonate and cardiovascular events in hypertensive adults: results from the Systolic Blood Pressure Intervention Trial
Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT
Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT
Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials
Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction
The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
Serum Sodium and Cognition in Older Community-Dwelling Men
Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants
A guiding map for inflammation
Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease